New stroke drug LT3001 tested in small safety trial

NCT ID NCT04091945

First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 16 times

Summary

This study tested a single dose of the experimental drug LT3001 in 24 adults who had an acute ischemic stroke within the past 24 hours. The main goal was to see if the drug causes dangerous bleeding in the brain compared to a placebo. The trial was small and early-stage, focused on safety rather than proving the drug works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Chattanooga Center for Neurologic Research

    Chattanooga, Tennessee, 37403, United States

  • China Medical University Hospital

    Taichung, Taiwan

  • JFK Neuroscience Institute, JFK Medical Center

    Edison, New Jersey, 08837, United States

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, Taiwan

  • Linkou Chang Gung Memorial Hospital

    New Taipei City, Taiwan

  • Taichung Veterans General Hospital

    Taichung, Taiwan

  • Taipei Medical University - Shuang Ho Hospital

    New Taipei City, Taiwan

  • Taipei Veterans General Hospital

    Taipei, Taiwan

  • The Ohio State University - Wexner Medical Center

    Columbus, Ohio, 43210, United States

  • University of Kentucky Chandler Medical Center

    Lexington, Kentucky, 40536, United States

Conditions

Explore the condition pages connected to this study.